USE OF BOARD AND UTMDACC’S NAME. 10.1. LICENSEE will not use the name of (or the name of any employee of) UTMDACC, SYSTEM or BOARD in any advertising, promotional or sales literature, on its Web site, or for the purpose of raising capital without the advance express written consent of BOARD secured through: The University of Texas M. D. Xxxxxxxx Cancer Center Legal Services, Xxxx 0000 X.X. Xxx 000000 Xxxxxxx, XX 00000-0000 ATTENTION: Xxxxxxx Xxxxxx Email: xxxxxxx@xxxxxxxxxx.xxx Notwithstanding the above, LICENSEE may use the name of (or name of employee of) UTMDACC, SYSTEM or BOARD in routine business correspondence, or as needed in appropriate regulatory submissions without express written consent.
Appears in 3 contracts
Samples: Patent and Technology License Agreement (Bridgetech Holdings International Inc), Patent and Technology License Agreement (Bridgetech Holdings International Inc), Patent and Technology License Agreement (Bridgetech Holdings International Inc)
USE OF BOARD AND UTMDACC’S NAME. 10.1. 10.1 LICENSEE will not use the name of (or the name of any employee of) UTMDACC, SYSTEM or BOARD in any advertising, promotional or sales literature, on its Web site, or for the purpose of raising capital without the advance express written consent of BOARD secured through: The University of Texas M. D. Xxxxxxxx Axxxxxxx Cancer Center Legal Services, Xxxx 0000 X.X. Xxx 000000 XxxxxxxUnit 0537 P.O. Box 301439 Houston, XX 00000TX 77230-0000 1439 ATTENTION: Xxxxxxx Xxxxxx Lxxx X. Xxxxxxxx Email: xxxxxxx@xxxxxxxxxx.xxx lxxxxxxx@xxxxxxxxxx.xxx Notwithstanding the above, LICENSEE may use the name of (or name of employee of) UTMDACC, SYSTEM or BOARD in routine business correspondence, or as needed in appropriate regulatory submissions without express written consent.
Appears in 1 contract
Samples: Patent and Technology License Agreement (Moleculin Biotech, Inc.)
USE OF BOARD AND UTMDACC’S NAME. 10.1. 10.1 LICENSEE will not use the name of (or the name of any employee of) UTMDACC, SYSTEM or BOARD in any advertising, promotional or sales literature, on its Web site, or for the purpose of raising capital without the advance express written consent of BOARD secured through: The University of Texas M. D. X. Xxxxxxxx Cancer Center Legal Services, Xxxx Uxxx 0000 X.X. Xxx 000000 Xxxxxxx, XX 00000-0000 ATTENTION: Xxxxxxx Nxxxxxx Xxxxxx Email: xxxxxxx@xxxxxxxxxx.xxx nxxxxxx@xxxxxxxxxx.xxx Notwithstanding the above, LICENSEE may use the name of (or name of employee of) UTMDACC, SYSTEM or BOARD in routine business correspondence, or as needed in appropriate regulatory submissions without express written consent.
Appears in 1 contract
Samples: Patent and Technology License Agreement (Bio-Path Holdings Inc)
USE OF BOARD AND UTMDACC’S NAME. 10.1. 10.1 LICENSEE will not use the name of (or the name of any employee of) UTMDACC, SYSTEM or BOARD in any advertising, promotional or sales literature, on its Web site, or for the purpose of raising capital without the advance express written consent of BOARD secured through: The University of Texas M. D. X. Xxxxxxxx Cancer Center Center, Legal ServicesServices P.X. Xxx 000000, Xxxx 0000 X.X. Xxx 000000 Xxxxxxx, XX 00000-0000 ATTENTION: Xxxxxxx Nxxxxxx Xxxxxx Email: xxxxxxx@xxxxxxxxxx.xxx nxxxxxx@xxxxxxxxxx.xxx Notwithstanding the above, LICENSEE may use the name of (or name of employee of) UTMDACC, SYSTEM or BOARD in routine business correspondence, or as needed in appropriate regulatory submissions without express written consent.
Appears in 1 contract
Samples: Confidential Treatment (Callisto Pharmaceuticals Inc)
USE OF BOARD AND UTMDACC’S NAME. 10.1. 10.1 LICENSEE will not use the name of (or the name of any employee of) UTMDACC, SYSTEM or BOARD in any advertising, promotional or sales literature, on its Web site, or for the purpose of raising capital without the advance express written consent of BOARD secured through: The University of Texas M. D. Xxxxxxxx Axxxxxxx Cancer Center Legal Services, Xxxx Uxxx 0000 X.X. X. X. Xxx 000000 Xxxxxxx, XX 00000-0000 ATTENTION: Xxxxxxx Xxxxxx Lxxx X. Xxxxxxxx Email: xxxxxxx@xxxxxxxxxx.xxx lxxxxxxx@xxxxxxxxxx.xxx Notwithstanding the above, LICENSEE may use the name of (or name of employee of) UTMDACC, SYSTEM or BOARD to disclose the existence or status of this AGREEMENT in routine business correspondence, or as needed in appropriate regulatory submissions submissions, or as required by law, in each case without express written consent.
Appears in 1 contract
Samples: Patent and Technology License Agreement (Moleculin Biotech, Inc.)